Roxro Announces FDA Approval of Sprix

Links shared publicly online about this topic.

  • 1,161
    total visits

Roxro Announces FDA Approval of Sprix

drugs.com

Sprix (ketorolac tromethamine) is used to treat pain. Includes Sprix side effects, interactions and indications.

View full resource at drugs.com

Tags: Pain, FDA, NSAIDs, Toradol

  • Share

Most Recently Shared on May 17, 2010 at 11:32 pm By:

drugscom Drugs.com

Roxro Announces FDA Approval of Sprix - http://bit.ly/bGt1Ii

2 years ago...

ROXRO Announces FDA Approval Of SPRIX(TM)

medicalnewstoday.com — “ROXRO PHARMA, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acuteView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 25, 2010 at 2:10 pm By:

ROXRO Announces FDA Approval of SPRIX - FiercePharma

fiercepharma.com — “ROXRO Announces FDA Approval of SPRIX (Ketorolac Tromethamine) - First Non-narcotic Intranasal Analgesic for Moderate to Moderately Severe Pain - Download image MENLO PARK, Calif., May 17... Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on May 17, 2010 at 6:38 pm By:

FDA approves ROXRO PHARMA's SPRIX Nasal Spray

news-medical.net — “ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX" (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 17, 2010 at 5:47 pm By:

Stroke_News News-Medical.Net Health News

Stroke News: FDA approves ROXRO PHARMA's SPRIX Nasal Spray: ROXRO PHARMA, Inc. announced today that the U.S. Foo... http://twurl.nl/jp5kc1

2 years ago...

Sprix approved for acute moderate to moderately severe pain - MPR

empr.com — “The FDA has approved Sprix (ketorolac tromethamine nasal spray, from Roxro Pharma) for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 17, 2010 at 4:55 pm By:

eMPR MPR Medical Publisher

MPR News: Sprix approved for acute moderate to moderately severe pain: The FDA has approved Sprix (ketorolac trome... http://bit.ly/beALNP

2 years ago...

Advertisement